loadpatents
name:-0.035527944564819
name:-0.022019147872925
name:-0.0033791065216064
Hayden; Michael R. Patent Filings

Hayden; Michael R.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Hayden; Michael R..The latest application filed is for "allele-specific therapy for huntington disease haplotypes".

Company Profile
3.23.33
  • Hayden; Michael R. - Vancouver CA
  • Hayden; Michael R. - Edina MN
  • Hayden, Michael R - Vancouver CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Allele-specific therapy for Huntington disease haplotypes
Grant 10,731,160 - Southwell , et al.
2020-08-04
Allele-specific Therapy For Huntington Disease Haplotypes
App 20200199595 - Southwell; Amber L. ;   et al.
2020-06-25
Allele-specific therapy for huntington disease haplotypes
Grant 10,533,172 - Southwell , et al. Ja
2020-01-14
Allele-specific Therapy For Huntington Disease Haplotypes
App 20170253877 - Southwell; Amber L. ;   et al.
2017-09-07
LPL variant therapeutics
Grant 9,290,751 - Hayden , et al. March 22, 2
2016-03-22
Treatment of vascular, autoimmune and inflammatory diseases using low dosages of IMPDH inhibitors
Grant 8,957,071 - Glickman , et al. February 17, 2
2015-02-17
Lpl Variant Therapeutics
App 20150030581 - HAYDEN; Michael R. ;   et al.
2015-01-29
Polymorphisms Predictive Of Platinum-coordinating Compound-induced Ototoxicity
App 20140147516 - Hayden; Michael R. ;   et al.
2014-05-29
Methods and reagents for modulating cholesterol levels
Grant 8,715,968 - Hayden , et al. May 6, 2
2014-05-06
Recombinant Viruses and their Use for Treatment of Atherosclerosis and Othe Forms of Coronary Artery Disease and Method, Reagent, and Kit for Evaluating Susceptibiity to Same
App 20130164262 - Benoit; Patrick ;   et al.
2013-06-27
Compositions And Methods For Treating Vascular, Autoimmune And Inflammatory Diseases
App 20110306608 - Hayden; Michael R. ;   et al.
2011-12-15
Polynucleotide encoding an ATP binding cassette transporter 1 (ABC1) polypeptide
Grant 8,067,219 - Hayden , et al. November 29, 2
2011-11-29
Lpl Variant Therapeutics
App 20110201673 - Hayden; Michael R. ;   et al.
2011-08-18
Multipurpose adjustable panel system
Grant 7,971,395 - Vigil , et al. July 5, 2
2011-07-05
Polymorphisms Predictive Of Platinum-coordinating Compound-induced Ototoxicity
App 20110104257 - Hayden; Michael R. ;   et al.
2011-05-05
Methods and reagents for modulating cholesterol levels
App 20110065147 - Hayden; Michael R. ;   et al.
2011-03-17
Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents
App 20110060014 - Hayden; Michael R. ;   et al.
2011-03-10
Stage system with connectable corner
Grant 7,895,792 - Hayden , et al. March 1, 2
2011-03-01
Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents
Grant 7,816,075 - Hayden , et al. October 19, 2
2010-10-19
Methods and reagents for modulating cholesterol levels
Grant 7,785,886 - Hayden , et al. August 31, 2
2010-08-31
Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents
Grant 7,696,151 - Hayden , et al. April 13, 2
2010-04-13
Stage system with connectable corner
Grant 7,624,540 - Hayden , et al. December 1, 2
2009-12-01
Recombinant viruses and their use for treatment of atherosclerosis and other forms of coronary artery disease and method, reagent, and kit for evaluating susceptibility to same
App 20090257981 - Benoit; Patrick ;   et al.
2009-10-15
Treatment of Vascular, Autoimmune and Inflammatory Diseases Using Low Dosages of IMPDH Inhibitors
App 20090088427 - GLICKMAN; Richard ;   et al.
2009-04-02
Compositions And Methods For Treating Vascular, Autoimmune, And Inflammatory Diseases
App 20080280932 - Hayden; Michael R. ;   et al.
2008-11-13
Cholesterol transport gene
App 20070298420 - Attie; Alan D. ;   et al.
2007-12-27
Cholesterol transport gene
Grant 7,166,584 - Attie , et al. January 23, 2
2007-01-23
Compositions and methods for treating vascular, autoimmune, and inflammatory diseases
App 20060235070 - Hayden; Michael R. ;   et al.
2006-10-19
Treatment of vascular, autoimmune and inflammatory diseases using low dosages of IMPDH inhibitors
App 20060235009 - Glickman; Richard ;   et al.
2006-10-19
Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents
Grant 6,987,001 - Hayden , et al. January 17, 2
2006-01-17
Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents
App 20050256033 - Hayden, Michael R. ;   et al.
2005-11-17
Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents
App 20050250160 - Hayden, Michael R. ;   et al.
2005-11-10
Recombinant viruses and their use for treatment of atherosclerosis and other forms of coronary artery disease and method, reagent, and kit for evaluating susceptibility to same
App 20050163754 - Benoit, Patrick ;   et al.
2005-07-28
Methods and reagents for modulating cholesterol levels
App 20050136421 - Hayden, Michael R. ;   et al.
2005-06-23
Methods for treating disorders of the nervous and reproductive systems
App 20050019765 - Wellington, Cheryl L ;   et al.
2005-01-27
Diagnostic methods for cardiovascular disease, low hdl-cholesterol levels, and high triglyceride levels
App 20050003356 - Hayden, Michael R. ;   et al.
2005-01-06
Compositions and methods for modulating HDL cholesterol and triglyceride levels
App 20040229275 - Hayden, Michael R. ;   et al.
2004-11-18
Recombinant viruses and their use for treatment of atherosclerosis and other forms of coronary artery disease and method, reagent, and kit for evaluating susceptibility to same
Grant 6,814,962 - Benoit , et al. November 9, 2
2004-11-09
Methods and reagents for modulating cholesterol levels
App 20040185508 - Hayden, Michael R. ;   et al.
2004-09-23
Gene therapy method for reducing risk of atherosclerosis
Grant 6,784,162 - Hayden , et al. August 31, 2
2004-08-31
Methods and reagents for modulating cholesterol levels
App 20040157250 - Hayden, Michael R. ;   et al.
2004-08-12
Als2 gene and amyotrophic lateral sclerosis type 2
App 20040137450 - Shinji, Hadano ;   et al.
2004-07-15
Compositions and methods for modulating HDL cholesterol and triglyceride levels
App 20040137423 - Hayden, Michael R. ;   et al.
2004-07-15
Methods and reagents for modulating cholesterol levels
App 20040058869 - Hayden, Michael R. ;   et al.
2004-03-25
Methods and reagents for modulating cholesterol levels
App 20040005666 - Hayden, Michael R. ;   et al.
2004-01-08
Process for identifying modulators of ABC1 activity
Grant 6,617,122 - Hayden , et al. September 9, 2
2003-09-09
Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents
App 20030157552 - Hayden, Michael R. ;   et al.
2003-08-21
Compositions, screening systems and methods for modulating HDL cholesterol and triglyceride levels
App 20030092157 - Hayden, Michael R. ;   et al.
2003-05-15
Stage system
Grant 5,935,675 - Hayden , et al. August 10, 1
1999-08-10
Method, reagent and kit for evaluating susceptibility to premature atherosclerosis
Grant 5,658,729 - Hayden , et al. August 19, 1
1997-08-19
Company Registrations
SEC0001352908Hayden Michael R

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed